Unlocking long-term value: Clinical trial productivity considerations for emerging biotechs

Clinical trials are more than a scientific milestone for emerging biotech companies, they are also a strategic lever for attracting investment, enabling collaborations, and positioning assets for acquisition or commercialization. Under pressure to quickly reach early proof-of-concept, often short-term decisions made can unintentionally limit long-term potential.